Print

Print


The Scientist 14[23]:20, Nov. 27, 2000
http://www.thescientist.com/yr2000/nov/research_001127.html

Liver
Goal: To develop a plentiful source of hepatocytes for regenerating
damaged livers and treating some metabolic diseases.

Another functional stem cell is the hepatocyte. "For liver repopulation
purposes and transplantation, the best cell type is the differentiated
hepatocyte," says Markus Grompe, a professor of molecular and medical
genetics and pediatrics at Oregon Health Sciences University. He adds
that in transplants, hepatocytes are "far superior" to liver stem cells,
whose existence has been established only in the past 12 months or so.

The major source of hepatocytes for therapeutic purposes, however, is human
cadavers. More accessible and plentiful are the liver stem cells residing in the
bone marrow, discovered by Neil D. Theise, an associate professor of
pathology at New York University School of Medicine, and colleagues.

Their proof: The Y chromosome pops up in some hepatocytes after male
marrow transplants into females.

Are these new liver cells functional? In a small-scale study of human
transplants,16 "We show such extensive engraftment that it's hard to avoid
the conclusion that this is a part of physiological regeneration," asserts Theise.
The next test is to use bone-marrow transplants to correct defective liver
function in animal models of some human metabolic diseases. Grompe and
a team of researchers published a paper this month reporting such a finding
in a mouse model of tyrosinemia.17

The roles played by ASCs in the liver are still far from clear. Intrahepatic
oval cells have recently--and grudgingly--won full acceptance as stem cells,
particularly after injury. (Theise proposes that oval cells ultimately derive
from the bone marrow.) Apparently no one has yet generated liver cells
from ESCs. The growth factors "are just absolutely not known," notes Grompe.

*********************